(Reuters) - Human Genome Sciences Inc has agreed to be acquired by GlaxoSmithKline Plc, subject to approval of some last-minute details, for about $14 a share in cash, two sources familiar with the situation said on Sunday.
via Reuters: Health News Read More Here..
No comments:
Post a Comment